Alzheimer's disease as well as prion-related encephalopathies are neurodegenerative disorders of the central nervous system, which cause mental deterioration and progressive dementia. Both pathologies appear to be primarily associated with the pathological accumulation and deposit of -amyloid or prion peptides in the brain, and it has been even suggested that neurotoxicity induced by these peptides would be associated to essentially similar pathogenic mechanisms, in particular to those that follow the activation of microglial cells. To probe whether the neurotoxic effects induced by the -amyloid and prion peptides are actually mediated by similar glial-associated mechanisms, we have examined the differential expression of genes in SH-SY5Y neuroblastoma cells incubated with conditioned media from -amyloid or prion-stimulated THP-1 monocytic cells. According to microarray analysis, not many coincidences are observed and only four genes (Hint3, Psph, Daam1 and c-Jun) appear to be commonly upregulated by both peptides. Furthermore, cJun appears to be involved in the cell death mediated by both peptides.
INTRODUCTION
Alzheimer and prion pathologies are neurodegenerative diseases characterized by the progressive loss of neuronal synaptic function, an effect that in both cases appears to be secondary to the toxicity induced by key proteins, the beta-amyloid (A) in Alzheimer's disease and PrP in prion pathologies, which accumulate and aggregate in the brain. At first sight, both types of pathologies exhibit different specific characteristics in relation with the mode of transmission, the etiology, or the frequency of occurrence, and they can be considered as essentially distinct pathologies (Checler & Vincent, 2002) .
However, despite these evident differences, these pathologies also show a number of similarities. In both cases neurodegeneration appears to be mediated by proteins that, as mentioned above, are aggregated and accumulated in the brain (Price et al., 1993) . Those proteins share a complex multi-domain structure and contain toxic sequences that mediate neurotoxicity and give rise to similar damaging apoptotic phenotypes (Checler & Vincent, 2002) . Moreover, they share a number of properties such as the presence of metal-binding sites that mediate the binding of metals ions, in particular copper or zinc (Barnham et al., 2006) , or the existence of several repeats of a GxxxG motif in the transmembrane region, which contain a methionine residue that appears to be essential to modulate the neurotoxicity of A in Alzheimer or the disease susceptibility in the prion associated pathologies (Barnham et al., 2006) . Evidence reported in those articles supported the hypothesis that neurotoxicity induced by both proteins, the amyloid and prion, would be mediated by similar, if not identical, molecular pathways and opened a very attractive possibility as is the use of common therapeutic strategies to treat and prevent Alzheimer's and prion diseases.
Unfortunately, this hypothesis appears to be too simplistic, and although it is evident that both the -amyloid and the PrP proteins are neurotoxic and induce similar processes of apoptosis and neurodegeneration, the factors and pathways that mediate these effects could be essentially different (Forloni et al., 1996; Hope et al., 1996; Brown et al., 1997) . In this sense, we have also reported that both the amyloid-beta 25-35 (A25-35) and the PrP106-126 fragments induce a distinct gene expression profile in the human SH-SY5Y neuroblastoma cell line. First, the number of genes significantly altered by these treatments was markedly different, 198 in the case of the prion (Martinez & Pascual, 2007b) , and 67 in the case of the amyloid fragment (Martinez & Pascual, 2007a) , and second, the relationship between the overexpressed and repressed genes was opposite in both cases (16/182 and 54/13, respectively).
Despite this, it has been also well established that in addition to those effects directly induced on neurons, neurotoxicity of both peptides can be largely mediated by microglia activation, and the consequent release of cytotoxic molecules such as proinflammatory cytokines or reactive oxygen intermediates. In fact, an increasing body of evidence indicates that neuronal death induced by the -amyloid and the prion peptides in the brain is mainly associated to processes that are promoted by activation of the surrounding microglial cells (Dheen et al., 2007) . To analyze possible coincidences between the neurotoxic effects induced by both peptides through activation of microglia, we have now analyzed the gene expression profile in SH-SY5Y neuroblastoma cells exposed to conditioned media obtained from A25-35 or PrP106-126 stimulated THP-1 human monocytic cells, which were used as a surrogate model of human microglia.
MATERIALS AND METHODS

Cell Culture and treatments
Human monocytic THP-1 cells and SH-SY5Y human neuroblastoma cells were cultured as previously described (Combs et al., 1999; Villa et al., 2002) in RPMI 1640 medium supplemented with 10% fetal bovine serum (Gibco.Life technologies Ltd. Paislay. Scotland. UK), and maintained at 37ºC in a 5% CO2 atmosphere. Synthetic A25-35 obtained from AnaSpec and synthetic PrP106-126 obtained from Neosystem, were prepared as follows: Briefly, A25-35 was dissolved in deionized-distilled water at a concentration of 2,5 mM and stored at −80 °C. Previous to the experiments, the stock solution was diluted to the desired concentrations and then added to the culture medium. The prion peptide 106-126 was dissolved in PBS at a concentration of 2 mM and maintained for 48 hours at room temperature to allow polymerization, before being added to the cells.
For experiments, THP-1 monocytes were incubated for 48 hours with or without 10 M A25-35 or 10M PrP106-126, and the conditioned media collected and centrifuged to eliminate cell residues. The cell-free supernatants were then used to replace the culture media of SH-SY5Y cells previously plated in 6-well plates and grown for 24 hours in RPMI/10%FBS media. Six hours after addition of conditioned media a set of cells was harvested for posterior RNA extraction and determination of gene expression. The remaining cells were incubated in the presence or in the absence of conditioned media for 24 hours and then photographed and fixed for histological analysis or collected and saved for subsequent protein or RNA extraction.
Fluorescence microscopy
SH-SY5Y cells were incubated for different time periods with the supernatants of amyloid-or prion-treated THP-1 cells or RPMI fresh medium, and then fixed with 4% paraformaldehyde at pH=7,4 and room temperature for 1 hour, permeabilized with 0,1% Triton-X-100, and then subjected to TUNEL assay to evaluate the cellular death by using the in situ cell death detection kit Fluorescein (Roche). To further confirm the findings of TUNEL assay, cells were washed with PBS, stained with DAPI, and analyzed by fluorescence microscopy, using a Zeiss Axiophot inverted fluorescence microscope (515-565 nm for TUNEL, and 450-480 nm for DAPI). Images of cells were then digitized using an Olympus DP70 color camera.
MTT cell viability assay
Cell viability was evaluated in 96-well culture plates using a colorimetric assay based on the reduction of tetrazolium dye (MTT) to a blue formazan product. After incubation for 4 h with MTT (0.5 mg/ml) at 37°C, isopropanol/HCl was added to each 96-well and the absorbance of solubilized MTT formazan products was measured spectrophotometrically at 570 nm.
RNA interference
Expression of c-Jun in the SH-SY5Y cells was inhibited by using the Santa Cruz Biotechnology c-Jun siRNA (h2) (catalog number sc-44201). Cells were grown to 60% confluence and the c-Jun siRNA or a control siRNA (catalog number sc-37007) were transfected (using the transfection reagent sc-29528) according to the manufacturer's instructions. At 24 h after transfection, the medium was replaced and the cells were further incubated for 48 h. Next, media were removed and the cells were exposed to the THP-1 conditioned supernatants for 24 h.
RNA preparation and Microarray Analysis
For RNA isolation cell lysates were homogenized and the RNA purified by using the QIAshredder and RNeasy Mini kits of Qiagen, according to the manufacturer's recommendations. The final amount of isolated RNA was determined in each sample by spectrophotometry and its quality assessed by electrophoresis on agarose gels.
Preparation of cDNA, cRNA, hybridization and scanning of microarrays were performed following manufacturer's protocols. cDNA, and biotinylated cRNAs were synthesized from 5g RNA samples with the GeneChip expression 3' amplification reagents (one-cycle cDNA synthesis, and IVT labelling) kits of Affymetrix, and biotinylated probes were hybridized to an Affymetrix gene chip human genome U133A Plus 2.0 array, a microarray that contains more than 54,000 probe sets and allows an accurate analysis of the quantitative expression of over 47,000 transcripts, including 38,500 well characterized human genes. Analysis for differential expression was performed using the R platform for statistical analysis (R Foundation for Statistical
Computing. Vienna) and several packages from the Bioconductor project (Gentleman et al., 2004; Carey et al., 2005) . The raw data were imported into R and pre-processed using the affy package and the robust multichip average method (Irizarry et al., 2003) . Genes were selected based on fold change. For this task an absolute fold change of 1.6 was used.
RT-PCR amplification of mRNA
RT-PCR was used to validate the differential expression of several A-or PrP-responsive genes detected in the microarray analysis. Total RNA was extracted from cell cultures as mentioned above and cDNA was prepared from 250 ng of RNA using the high-capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA). For quantitative PCR, a cDNA aliquot corresponding to 5 ng of the starting RNA was used, with Taqman Assay-onDemand primers and the Taqman universal PCR master mix, No Amp Erase UNG (Applied Biosystems) on a 7900HT fast real-time PCR system (Applied Biosystems). The PCR program consisted in a hot start of 95 C for 10 min, followed by 40 cycles of 15 sec at 95 C and 1 min at 60 C. PCRs were performed in triplicates, using the 18S gene as internal standard and the 2-cycle threshold method for analysis (Livak & Schmittgen, 2001 ).
Statistical analysis.
When appropriate, the significance of differences was calculated with the Student's t test, and it was indicated in the corresponding figure by the following symbol: * p < 0,05 and ** p< 0.01.
RESULTS
Effects of the THP-1 conditioned medium on neuronal morphology and viability.
It is widely accepted that both the -amyloid and prion peptides induce microglial activation and the subsequent secretion of cytokines and neurotoxic reactive oxygen species (Forloni et al., 1993; Klegeris et al., 1997) , which in turn may increase neuronal apoptosis (Dheen et al., 2007) .
To further analyze and compare how the -amyloid-and prion-stimulated microglia may affect neurons, we have exposed SH-SY5Y neuroblastoma cells to conditioned media obtained from THP-1 cells, a monocytic cell line that exhibits responses to stimuli similar to those of microglia (Combs et al., 1999) . 
Gene expression profile in SH-SY5Y cells incubated in THP-1 cellsconditioned culture media.
To analyze how the amyloid-and prion-activated microglia may affect the gene expression profiling in neurons, SH-SY5Y cells were exposed to conditioned media for a 6 hours time period and then harvested and saved for posterior RNA extraction and microarray analysis. Gene expression was analyzed by using an Affymetrix U133A plus2 array and the data analyzed as described under Materials and Methods.
As expected, both the amyloid-and prion-conditioned media induced changes on the gene expression profile of treated SH-SY5Y cells. A significance analysis of microarrays highlighted a relatively high number of transcripts differentially expressed in cells exposed to conditioned media from the THP-1 monocytic cells stimulated by the amyloid or prion fragments.
However, the intensity of the response was rather low and not many genes change their expression by more than 1.6-fold. Of interest, the gene expression profiles appear to be different in both cases. First, the number of genes that change their expression appears to be much higher in amyloid-treated cells than in those cells exposed to the prion-conditioned medium. Second, whereas the genes affected by the prion-induced media appear to be mainly upregulated, the genes differentially expressed in cells exposed to the amyloidconditioned media were largely down-regulated. These results are illustrated in the Venn diagram shown in figure 3, which outlines the total number of sequences up-and down-regulated, as well as the number of coincidences, detected in cells exposed to both treatments. As illustrated in this figure, a total of 168 sequences, 19 upregulated and 149 down-regulated, in cells exposed to the amyloid peptide-conditioned media, and a total of 17 sequences, all of them upregulated, in the cells treated with the prion-conditioned media, were found to be differentially expressed (above 1,6 fold with respect to control). After subtracting non annotated sequences and repeated probes the number of amyloid-and prion-induced genes were reduced to 141 (129 down-and 12 upregulated) and 11 (all of them upregulated), respectively. Furthermore, four of these sequences appeared to be commonly upregulated by both treatments.
The lists of the differentially expressed transcripts has been included in tables 1 (amyloid) and 2 (prion), which, as mentioned before, only include transcripts showing a 1,6-fold variation above or below the level found in the control.
Validation of the microarray data
To confirm the results obtained in the microarray analysis, the expression of a subset of genes selected from those identified in the microarray was analyzed by real-time PCR performed with cDNAs prepared from the RNAs of SH-SY5Y cells treated, or untreated, with conditioned media recovered from prion-or amyloid-stimulated THP-1 cells.
Transcripts chosen for confirmation included a total of 9 genes selected among those commonly deregulated by both the prion-and amyloidconditioned media and/or because of their involvement in development and plasticity of the nervous system. As expected, the results from real-time PCR analysis were comparable to those provided by microarray analysis and, although in some of the samples the intensity of the response was different to that expected, all the transcripts analyzed showed the predicted differential expression patterns. Figure 4 shows the results obtained for five of these genes, two of them (JUN and DAAM1) commonly regulated by both treatments, and other three genes (STMN4, CREB5, and ETNK1) selected because of their contribution to the Jun-dependent signaling pathways. In agreement with the microarray data, four of these genes appear to be upregulated by both treatments, whereas ETNK1 that is down regulated in the amyloid treated cells remains unchanged in cells treated with the prion-stimulated medium. In addition, the differences obtained with the other analyzed genes (HINT3, CREB1, BCLAF1 and MAP3K) were not significant, but also showed the same tendency observed in the microarrays (not shown).
c-Jun silencing decreases the monocytic-mediated cell death
To further prove the role of c-Jun in the apoptotic signals induced by the amyloid and prion peptides, we also analyzed the levels of activated caspase-3 and the cell viability in SH-SY5Y cells transfected with a specific c- 
DISCUSSION
Neurodegenerative diseases, in particular Alzheimer´s disease and prion associated pathologies have been shown to share a number of characteristics and it has been even suggested that neurotoxicity induced by both, the amyloid and prion proteins, would be mediated by similar, if not identical, molecular pathways and mechanisms. In this sense, several factors have been already pointed as common targets of A and prions (Ferreiro et al., 2006; Ferreiro et al., 2007; Lopes et al., 2007) , and common therapies based on these descriptions have been suggested (Checler & Vincent, 2002; Barnham et al., 2006) . In contrast, a number of discordances have been also described. As shown in a number of in vitro studies, A and PrP peptides appear to induce neuronal apoptosis through different mechanisms (Forloni et al., 1996; Hope et al., 1996) (Brown et al., 1997) . Also in this line, we have described different gene expression profiles in neuroblastoma cells directly exposed to A25-35 and PrP106-126 synthetic fragments (Martinez & Pascual, 2007b; a) . However, in these reports we just described the effects directly induced by the prion and amyloid proteins on neurons, whereas neurotoxicity of both peptides has been proved to be further enhanced by the presence of glial (mostly microglial) cells (Dheen et al., 2007) . In fact, the number of glial cells has been described to correlate with the amyloid or prion deposition (Van Everbroeck et al., 2004) , and it has been suggested that activation of microglia by A or PrP and the subsequent release of cytokines, reactive oxygen species and other neurotoxic factors would be the main cause of the enhanced apoptosis and neuronal death observed both in Alzheimer and prion diseases. To analyze possible coincidences in the microglia-mediated neuronal response to those peptides we have exposed neuroblastoma SH-SY5Y cells to conditioned media obtained from A-or PrP-stimulated THP-1 monocytic cells, a established cell line widely used as a model for human microglia because of their functional similarities with primary microglia and their ability to activate similar signalling pathways (McDonald et al., 1997; Combs et al., 1999) . As expected, exposure of neuroblastoma cells to conditioned media from A or PrP-treated THP-1 cells caused a significant increase of cell death that was clearly detectable by optical microscopy, and further proved by TUNEL staining and caspase-3 activation. In addition, we have also identified a number of genes whose expression appears to be deregulated in cells exposed to conditioned media. In both cases, it is noteworthy that amyloid-associated effects were always more evident that those induced by the prion-stimulated medium. First, the A25-35 conditioned media appeared to be more toxic than that conditioned by PrP106-126 and apparently caused a higher lethality, as observed by optical microscopy.
Second, in contrast to that observed when these peptides act directly on neurons (Martinez & Pascual, 2007b; a) , the number of genes deregulated by A25-35 was markedly higher than the number of genes affected by the prionconditioned media. Indeed, whereas A25-35-induced medium changes the expression of 141 genes by more than 1,6-fold with respect to the control group, only 11 genes were altered by the PrP106-126 fragment.
On the other hand, a comparative analysis of these results with those previously described in neuroblastoma cells directly exposed to the amyloid or prion fragments, shows a number of additional differences between the direct and macrophage-mediated effects induced by both peptides. So, whereas the amyloid fragment appears to activate similar pathways and processes both acting directly on neurons or indirectly through monocytic activation, the effects of the PrP106-126 peptide are largely different when exerted directly or indirectly on neurons.
Despite these marked differences, it is remarkable the common activation of four genes in cells exposed to both treatments; Hint3, which has not been previously associated to neurodegenerative pathologies; Psph that is widely expressed in neuronal ganglia and Daam1 and c-Jun, which as previously described play a role in the developing and injured nervous system (Kida et al., 2004; Zhou et al., 2004) . In particular, it results of interest the macrophagemediated upregulation of c-JUN, a gene that has been associated to axon regeneration (Raivich et al., 2004; Zhou et al., 2004) , to brain inflammation and to a wide number of processes involved in neuronal cell death and degeneration (Raivich, 2008) . Moreover, a direct relationship between the JNK/c-Jun cascade and the Alzheimer's disease (Sun et al., 2009) or prionrelated pathologies (Lee et al., 2005) has been suggested. In the present study the role of c-Jun in the apoptotic processes induced by the A25-35 and PrP106-126 peptides has been confirmed by the reduced levels of cleaved caspase-3, an apoptotic marker, and the partial reversal of the cell viability reduction found in SH-SY5Y cells depleted of c-Jun by means of a specific siRNA.
In conclusion, our data show a number of divergences between the genes and mechanisms that mediate the neurotoxicity of A and PrP peptides but, remarkably, also show the common activation of a reduced number of genes including c-Jun, which codes for a transcription factor largely involved in apoptotic processes. In this sense, PCR analysis also shows the upregulation of Creb5 a member of the CRE (cAMP response element)-binding protein family, which as previously reported (Dong et al., 2007) may specifically interact with cJun and function as a CRE-dependent transactivator. These results further confirm previous descriptions about the role of c-Jun in neurodegenerative processes and reinforce the JNK/c-Jun pathway as a valuable target for the development of common therapeutic strategies. However, it is also true that our experiments have been carried out using two established cell lines as models, and it could occur that they do not accurately reflect the microglial-mediated neuronal toxicity that both the amyloid and prion peptides exert in vivo. In any case, these results might contribute to increase the knowledge about the mechanisms that mediate the neurotoxicity of both the amyloid and the prion peptides and should be useful to develop new and specific multitargeted therapies for these diseases. Table 2 . Deregulated genes in SH-SY5Y cells incubated for 6 hours with media conditioned by PrP106-126-treated THP-1 cells. Table includes upregulated genes that change their expression by more than 1.6-fold with respect to the control group. Not genes were found decreasing their expression by more than 1,6-fold. List does not included non annotated or repeated genes. In this paper we have analyzed the monocyte-mediated gene expression profile induced by the amyloid an prion peptides in the human SH-SY5Y neuroblastoma cell line. Results show a relevant coincidence in activating the expression of four genes Hint3, Psph, Daam1 and c-Jun. Furthermore, c-Jun appears to be involved in the cell death mediated by both peptides.
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Answers to reviewer 2
As requested, we have now included those results not illustrated or mentioned as not shown in the former manuscript. They are shown in the new figures 1 and 5, and a short description has been added into the text and legends.
-As indicated in our previous version "the effect was not induced by scrambled sequences and was not observed with doses of A25-35 or PrP106-126 lower 5M (data not shown)". These results have been now included in figure 1A , although because their extension in the new figure we have just included the results corresponding to the higher dose of those compound, that is 5M. Of course, if you consider it is necessary, we could also include the results obtained with the other doses tested (1 and 2 M), that of course were also unable to reduce cell viability.
-In addition, the results obtained in the MTT assay have been included in figure  5 . Now it is possible to observe how the reduction of cell viability induced by both fragments is partially reversed in cells transfected with the c-Jun siRNA, thus suggesting a role for Jun in those processes.
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